FDA Inspection
Boehringer Ingelheim Fremont, Inc.Boehringer Ingelheim Fremont, Inc. – FDA Inspection, Apr 4, 2017
Record Details
This FDA Inspection record concerns Boehringer Ingelheim Fremont, Inc., with an inspection on April 4, 2017, issued by the San Francisco District Office, covering human drugs.
- People
- Diane L. Raccasi (Issuing Officer)
- Ephrem T. Hunde (Issuing Officer)
- Kristin M. Abaonza (FDA Associated Person)
- Maria I. Cruz-Fisher (Issuing Officer)
- Monica M. Commerford (Issuing Officer)
View Company Profile
ID · ff7cd87f-90a8-4b66-8652-6004f0512e9e
Inspection Facts
- Inspection number
- 1005958
- FDA center
- Human Drugs
- Outcome
- Form 483 issued
Other FDA inspections of Boehringer Ingelheim Fremont, Inc.
7| Date | Classification | Office | Project area |
|---|---|---|---|
| May 16, 2024 | Not classified | San Francisco District Office | |
| April 13, 2023 | Not classified | San Francisco District Office | |
| November 4, 2022 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 24, 2018 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 28, 2014 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Boehringer Ingelheim Fremont, Inc.
- FDA Inspection 1263388 - 2024-05-16
- FDA Inspection 1205076 - 2023-04-13
- FDA Inspection 1187410 - 2022-11-04
- FDA Inspection 1063730 - 2018-08-24
- FDA Inspection 882791 - 2014-05-28
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.